Hygroton

Chlortalidone, the active ingredient in Hygroton, is a thiazide‑like diuretic presented as an oral tablet for oral use. It is employed to lower elevated blood pressure and to reduce fluid accumulation in conditions such as heart failure, renal disease, or liver cirrhosis.

GNH USA supplies Hygroton as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product meets European Union quality standards, is distributed under a prescription‑only status, and our supply chain ensures consistent availability and compliance with regulatory requirements across global markets.

Chlortalidone is indicated for several cardiovascular and renal conditions where fluid overload or high blood pressure is present.

Hypertension: helps lower elevated blood pressure and reduce cardiovascular risk. Edema associated with heart failure: promotes fluid loss to relieve swelling and improve symptoms. Edema due to renal disease: enhances urinary excretion to manage fluid retention in kidney disorders. Edema due to liver cirrhosis: assists in reducing ascites and peripheral edema in cirrhotic patients.

Chlortalidone may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Increased urination: frequent need to void. - Dizziness or light‑headedness: especially after standing. - Electrolyte disturbances (low potassium, sodium): may cause muscle cramps. - Elevated blood glucose: can worsen diabetes control.

Serious or Rare Side Effects: - Severe electrolyte imbalance (hypokalemia, hyponatremia): may lead to cardiac arrhythmia. - Acute gout attacks: sudden joint pain due to uric acid rise. - Allergic reactions (rash, angioedema, anaphylaxis): require immediate medical attention.

When prescribing chlortalidone, clinicians should consider several safety precautions.

- Monitor electrolytes: check serum potassium, sodium and magnesium regularly. - Assess renal function: avoid use in severe renal impairment. - Evaluate blood pressure: ensure adequate control without excessive hypotension. - Caution in diabetes: monitor blood glucose as the drug may increase levels. - Pregnancy and lactation: category B, use only if benefits outweigh risks. - Store at ambient temperature: keep below 25 °C, retain in original packaging and protect from moisture.

Chlortalidone can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Lithium: increased lithium levels may cause toxicity. - NSAIDs (e.g., ibuprofen): may reduce diuretic effect and impair kidney function. - ACE inhibitors or ARBs: combined use can cause excessive potassium loss and renal dysfunction.

Moderate Interactions (Monitor Closely): - Antidiabetic agents: may require dose adjustment due to raised glucose. - Antihypertensives (beta‑blockers, calcium channel blockers): risk of additive blood pressure lowering. - Digoxin: altered serum levels may occur, monitor for toxicity.